Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.

Slides:



Advertisements
Similar presentations
Integrating Family Planning Services into an STD Clinic Setting J. Shlay, D. Bell, M. Maravi, C. Urbina, and the entire Denver Metro Health Clinic Staff.
Advertisements

European Guidelines for the HIV Treatment Esteban Martínez Infectious Diseases Unit Hospital Clínic University of Barcelona Barcelona SPAIN.
Rare Film Guide Slide Set. Clinical Trial Design for Pirfenidone Study Purpose of Study: To see if the use of pirfenidone decreases the loss of lung function.
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum Module 9 Special Populations.
Outpatient Treatment Ellen A. Ovson, M.D. Medical Director
Opioid Update F ederation of S tate M edical B oards Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain July 2013 F ederation.
JANUARY 2013 SUBSTANCE ABUSE TREATMENTBASICS. WHY DO PEOPLE USE DRUGS AND ALCOHOL? People use substances such as alcohol and other drugs because they.
Accommodation Plans.  Civil Rights legislation for persons with disabilities indicates that schools must afford students with disabilities equal opportunities.
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
Integrating Oral Health Care into the Management of Children With HIV Infection: Models of Interdisciplinary Care.
Mental Health Cindy Dawson CYC (Cert.) r. Mental Health Centralized Intake for CHEO/ROMHC Youth Program Any referrals for services at CHEO or the Royal.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
“The ACSS team serves primarily individuals who are experiencing a major mental illness requiring longer term case management in the community to achieve.
F/C AETC Faculty HIV HCV Thursday, March 12, 2015 | 1:30pm EDT Medical Facilitator/Didactic Presenter Todd S. Wills, MD University of South Florida Case.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Attractive Addiction Treatment...? Can we make addiction treatment engaging?
® Introduction Back Pain Flare Ups, Physical Function, and Opioid Use Adriana Gonzalez, Darryl White MD, Sandra Burge PhD The University of Texas Health.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
1 First Clinic Visit for Patients with HIV Infection HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Medicare Annual Wellness Exam Presented by: Susan Duden, CPC. March 24, 2012.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
Module V: Coordinated Care BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Buprenorphine Treatment: Patient Selection and Coordinated Care Thomas E. Freese, Ph.D. UCLA Integrated Substance Abuse Programs
Substance Use & Abuse in Pregnancy Janet L. Mitchell, M.D., M.P.H., F.A.C.O.G. Consultant on Women’s Health Addiction Research & Treatment Corporation.
Emotional and Psychiatric Barriers to Addressing HCV Joan E. Zweben, Ph.D. Executive Director: 14 th Street Clinic and East Bay Community Recovery Project.
For Pain or Not for Pain: Methadone Madness
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
ADOLESCENTS IN CRISIS: WHEN TO ADMIT FOR SELF-HARM OR AGGRESSIVE BEHAVIOR Kristin Calvert.
Services Overview: Mental Health/Substance Use Disorders Programs and Managed Care Plans 1 Medi-Cal Managed Care Plans (MCP) County Mental Health Plan.
New Referral Received: Outpatient Appointment Central Booking: Sends Family Form 1 To Family Family: Completes Family Form 1 To Central Booking Central.
Raymond F. Anton, MD for The COMBINE Study Research Group
Program Components and Key Concepts for Drug Court Services Matrix Institute on Addictions Rancho Cucamonga, California – 2001.
SCREENING BRIEF INTERVENTION AND REFERRAL TO TREATMENT (SBIRT) 1.
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
BUPRENORPHINE TREATMENT Curriculum Infusion Package (CIP) Based on the Work of Dr. Thomas Freese of the Pacific Southwest ATTC Drug Addiction Treatment.
Use of Opioids fro Chronic Pain in Primary Care Norman Wetterau MD
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
Evidence Based Medicine. What is Evidence Based Medicine? What qualifies as Evidence Based Medicine? Does Airrosti treat patients by utilizing an Evidence.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
Providing brief addictions treatment in an emergency department: Experiences of University of New Mexico Hospital research interventionists in the SMART-ED.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
H Department of Medical Assistance Services Substance Abuse Day Treatment 2013.
Agency Introduction Detailed Session – Day 2.  Intake Evaluations/Assessments ◦ Clinical eligibility  Diagnostic Justification Rationale ◦ Risk assessment.
An unpleasant sensory or emotional experience associated with actual or potential tissue damage The World Health Organization (WHO) has stated that pain.
Evidence-based practice guidelines: Chronic harms of substance use.
Given the progress that continues to be made in society’s battle against disease, patients are seeking more information about medical problems and potential.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
CLINICAL TRIALS.
Medication Assisted Treatment
Current Concepts in Pain Management
Medication-Assisted Therapy at Coleman Profession Services
MWCC.MS.GOV  Services  Medical Fee Schedule
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
North Carolina TASC Clinical Series Training
Opioid Prescribing & Monitoring
PSY 6670 Diagnosis & Treatment Planning Lecture 4 : Schizophrenia Spectrum Disorders Treatment Planning Joel Fairbanks, Ph.D.
A Training For Multidisciplinary Addiction Professionals
Information for Network Providers
Dr. Wilfried Kunstmann - German Medical Association - Berlin
Essentials of Good Pain Care: A Team-Based Approach
Guideline for the Treatment of Alcohol Use Disorder in the Outpatient Setting with Intramuscular Naltrexone Assess Candidacy for IM Naltrexone Meets DMS-V.
A Training For Multidisciplinary Addiction Professionals
Medically assisted treatment
Tapering and Discontinuing Chronic Opioid Therapy
Presentation transcript:

Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

Module IV – Goals of the Module This module will help participants to: Define the components of the patient selection process Demonstrate the ability to understand the concept of opioid addiction and how a diagnosis is achieved Demonstrate an understanding of appropriate patient selection for office- based treatment

Module IV – Goals of the Module, Continued This module will help participants to: List circumstances where someone may not meet full criteria for opioid addiction and yet still be appropriate for office-based treatment Describe the medical contraindications for buprenorphine treatment Understand the perspectives of patients who are receiving buprenorphine treatment

Where Are Opioid-Addicted Patients Seen? Pain clinics Doctors’ offices Psychiatric clinics Outpatient treatment centers Residential treatment programs Methadone clinics Health care clinics Infectious disease clinics Courts Etc…

Who is Appropriate for Buprenorphine Treatment?

Patient Selection: Assessment Questions Is the patient addicted to opioids? Is the patient aware of other available treatment options? Does the patient understand the risks, benefits, and limitations of buprenorphine treatment? Is the patient expected to be reasonably compliant? Is the patient expected to follow safety procedures?

Patient Selection: Assessment Questions Is the patient psychiatrically stable? Is the patient taking other medications that may interact with buprenorphine? Are the psychosocial circumstances of the patient stable and supportive? Is the patient interested in office-based buprenorphine treatment? Are there resources available in the office to provide appropriate treatment?

Patient Selection: Issues Involving Consultation with the Physician Several factors may indicate a patient is less likely to be an appropriate candidate, including: Patients taking high doses of benzodiazepines, alcohol or other central nervous system depressants Significant psychiatric co-morbidity Multiple previous opioid addiction treatment episodes with frequent relapse during those episodes (may also indicate a perfect candidate) Nonresponse or poor response to buprenorphine treatment in the past

Several factors may indicate a patient is less likely to be an appropriate candidate, including: Active or chronic suicidal or homicidal ideation or attempts Patient needs that cannot be addressed with existing office-based resources or through appropriate referrals High risk for relapse to opioid use Poor social support system Patient Selection: Issues Involving Consultation with the Physician

Pregnancy Currently buprenorphine is a Category C medication. This means it is not approved for use during pregnancy. Studies conducted to date suggest that buprenorphine may be an excellent option for pregnant women. Randomized trials are underway to determine the safety and effectiveness of using buprenorphine during pregnancy. Patient Selection: Issues Involving Consultation with the Physician

Patients with these conditions must be evaluated by a physician for appropriateness prior to buprenorphine treatment: Seizures HIV and STDs Hepatitis and impaired hepatic function Use of alcohol, sedative-hypnotics, and stimulants Other drugs Patient Selection: Issues Involving Consultation with the Physician

Patient Selection: Additional Details Suitability determined by a physician What is the relevance to counselors? Patient’s appropriateness may change during treatment Potential patients or other providers may inquire about treatment More useful and informed communication with physician

Patient Selection Patients who do do not meet criteria for opioid addiction may still be appropriate for treatment with buprenorphine Patients who are risk of progression to addiction or who are injecting Patients who have had their medication discontinued and who are now at high risk for relapse

Case Studies: “Put Your Smack Down!” A video from the O.A.S.I.S. Clinic, Oakland, CA

Group discussion of cases presented in “Put Your Smack Down! A Video about Buprenorphine”

Module IV – Summary Not all opioid-addicted patients are good candidates for office-based buprenorphine treatment. Ten simple criteria can help to guide assessment of appropriateness for buprenorphine treatment. Patients who have certain medical conditions such as HIV, STDs, hepatitis, etc., should be carefully screened by a physician prior to being started on buprenorphine.